Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC616818727;18728;18729 chr2:178729751;178729750;178729749chr2:179594478;179594477;179594476
N2AB585117776;17777;17778 chr2:178729751;178729750;178729749chr2:179594478;179594477;179594476
N2A492414995;14996;14997 chr2:178729751;178729750;178729749chr2:179594478;179594477;179594476
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCC
  • RefSeq wild type template codon: CGG
  • Domain: Ig-45
  • Domain position: 64
  • Structural Position: 144
  • Q(SASA): 0.114
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/T rs764768881 -1.37 0.006 N 0.255 0.191 0.280181792013 gnomAD-2.1.1 1.79E-05 None None None None N None 0 0 None 0 0 None 0 None 0 3.91E-05 0
A/T rs764768881 -1.37 0.006 N 0.255 0.191 0.280181792013 gnomAD-3.1.2 6.57E-06 None None None None N None 0 0 0 0 0 None 0 0 1.47E-05 0 0
A/T rs764768881 -1.37 0.006 N 0.255 0.191 0.280181792013 gnomAD-4.0.0 2.16901E-05 None None None None N None 1.33504E-05 0 None 0 0 None 0 0 2.88197E-05 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.5187 ambiguous 0.4956 ambiguous -1.737 Destabilizing 0.973 D 0.62 neutral None None None None N
A/D 0.5992 likely_pathogenic 0.6223 pathogenic -1.81 Destabilizing 0.505 D 0.653 neutral N 0.519390668 None None N
A/E 0.5347 ambiguous 0.5685 pathogenic -1.801 Destabilizing 0.404 N 0.641 neutral None None None None N
A/F 0.482 ambiguous 0.5265 ambiguous -1.35 Destabilizing 0.906 D 0.663 neutral None None None None N
A/G 0.1685 likely_benign 0.1883 benign -1.471 Destabilizing 0.174 N 0.537 neutral N 0.519137178 None None N
A/H 0.7543 likely_pathogenic 0.7773 pathogenic -1.412 Destabilizing 0.973 D 0.659 neutral None None None None N
A/I 0.2498 likely_benign 0.273 benign -0.596 Destabilizing 0.826 D 0.681 prob.neutral None None None None N
A/K 0.7932 likely_pathogenic 0.8132 pathogenic -1.319 Destabilizing 0.404 N 0.638 neutral None None None None N
A/L 0.2259 likely_benign 0.2457 benign -0.596 Destabilizing 0.575 D 0.599 neutral None None None None N
A/M 0.2823 likely_benign 0.3107 benign -0.741 Destabilizing 0.991 D 0.655 neutral None None None None N
A/N 0.4583 ambiguous 0.4878 ambiguous -1.298 Destabilizing 0.704 D 0.669 neutral None None None None N
A/P 0.3274 likely_benign 0.3475 ambiguous -0.76 Destabilizing 0.879 D 0.683 prob.neutral D 0.538758939 None None N
A/Q 0.6192 likely_pathogenic 0.6567 pathogenic -1.471 Destabilizing 0.826 D 0.687 prob.neutral None None None None N
A/R 0.7127 likely_pathogenic 0.7366 pathogenic -0.984 Destabilizing 0.826 D 0.678 prob.neutral None None None None N
A/S 0.1095 likely_benign 0.1176 benign -1.724 Destabilizing 0.001 N 0.245 neutral N 0.520018463 None None N
A/T 0.0978 likely_benign 0.105 benign -1.614 Destabilizing 0.006 N 0.255 neutral N 0.492813219 None None N
A/V 0.1231 likely_benign 0.1308 benign -0.76 Destabilizing 0.505 D 0.58 neutral N 0.446725852 None None N
A/W 0.8644 likely_pathogenic 0.8809 pathogenic -1.621 Destabilizing 0.991 D 0.673 neutral None None None None N
A/Y 0.6899 likely_pathogenic 0.7229 pathogenic -1.216 Destabilizing 0.906 D 0.672 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.